Target Name: LOC105377858
NCBI ID: G105377858
Review Report on LOC105377858 Target / Biomarker Content of Review Report on LOC105377858 Target / Biomarker
LOC105377858
Other Name(s): uncharacterized LOC105377858 | LOC105377858 variant X1 | Uncharacterized LOC105377858, transcript variant X1

LOC105377858: A Potential Drug Target for Neurodegenerative Diseases

LOC105377858 is a protein that is expressed in various tissues throughout the body. It is a member of the LOC105377859 family, which is characterized by the presence of a single transmembrane domain and a unique N-terminal region that is rich in conserved putative interactions with other proteins. LOC105377858 has been identified as a potential drug target due to its unique structure and the involvement of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The LOC105377858 protein is a transmembrane protein that is expressed in a variety of tissues, including the brain, pancreas, and heart. It is characterized by a single transmembrane domain that is responsible for its unique structure and function. This domain is rich in conserved putative interactions with other proteins, which suggests that it plays an important role in cell signaling and biology.

One of the most significant features of LOC105377858 is its unique N-terminal region. This region is rich in conserved putative interactions with other proteins, including the protein SMIT, which is also known as S100P. This interaction suggests that LOC105377858 may play a role in regulating the activity of SMIT, which is a protein that is involved in a variety of cellular processes, including cell signaling, DNA damage repair, and neurodegeneration.

In addition to its conserved interactions with SMIT, LOC105377858 has also been shown to interact with several other proteins, including the protein USP9. USP9 is a scaffold protein that is involved in the regulation of actin dynamics and cytoskeletal organization. This interaction suggests that LOC105377858 may play a role in regulating actin dynamics and cytoskeletal organization, which could have implications for a variety of cellular processes.

The potential drug targets for LOC105377858 are vast and varied. Given its unique structure and the involvement of several diseases, it is likely that LOC105377858 will be a valuable drug target for researchers to study. For example, LOC105377858 has been shown to be involved in the regulation of neurodegenerate diseases, including Alzheimer's disease and Parkinson's disease. Therefore, drugs that target LOC105377858 may be effective in treating these conditions.

In addition to its potential drug targets, LOC105377858 also has implications for the study of cancer. Given its involvement in cell signaling and regulation, it is possible that LOC105377858 may be involved in the regulation of cancer cell growth and metastasis. Therefore, drugs that target LOC105377858 may be effective in treating a variety of cancers.

Overall, LOC105377858 is a unique and promising protein that has the potential to be a drug target. Its unique structure and the involvement of several diseases make it an attractive target for researchers to study, and its potential drug targets are vast and varied. Further research is needed to fully understand the role of LOC105377858 in cell biology and disease.

Protein Name: Uncharacterized LOC105377858

The "LOC105377858 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377858 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920